Earnings History Data for Cidara Therapeutics, Inc. (CDTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives. Its product pipeline includes CD101 IV, a long-acting echinocandin antifungal, CD101 topical and C001 which are in different clinical trial. The company developed its product using Cloudbreak(TM) immunotherapy platform. Cidara Therapeutics, Inc. is headquartered in San Diego, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-05-2025	AH		CDTX	Cidara Therapeutics, Inc.	215.73	-1.66	-5.45	-2.28	Cidara Therapeutics GAAP EPS of -$1.66 beats by $1.91 [5/8/2025 5:17 PM]	18.64	-0.51 (-2.66%)	18.50	-0.65 (-3.39%)	10.14 - 28.42	54,238	80,000	291
Cidara Therapeutics GAAP EPS of -$1.66 beats by $1.91 [5/8/2025 5:17 PM] Cidara Therapeutics files $500M mixed securities shelf [5/8/2025 5:29 PM] Cidara Therapeutics: Q1 Earnings Snapshot [2025-05-08 04:38PM] Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results [2025-05-08 04:15PM] Cidara Therapeutics Inc (CDTX) Q1 2025 Earnings Call Highlights: Promising Advances in ... [2025-05-09 03:48AM]
06-03-2025	AH		CDTX	Cidara Therapeutics	163.00	-5.38	-5.28	0.00	Cidara Therapeutics GAAP EPS of -$5.37 misses by $1.52 [3/6/2025 4:50 PM]	23.22	-0.39 (-1.65%)	23.40	-0.21 (-0.89%)	10.00 - 28.42	44,776	100,000	751
Cidara Therapeutics GAAP EPS of -$5.37 misses by $1.52 [3/6/2025 4:50 PM] Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results [2025-03-06 04:35PM] Cidara Therapeutics: Q4 Earnings Snapshot [2025-03-06 05:03PM]
13-08-2024	AH		CDTX	Cidara Therapeutics	83.00	-2.05	-3.94	0.00	Cidara Therapeutics GAAP EPS of -$20.65, revenue of $0.3M [8/13/2024 5:36 PM]	12.78	0.63 (5.19%)	12.55	0.40 (3.29%)	10.00 - 24.40	41,156	10,000	1,230
Cidara Therapeutics GAAP EPS of -$20.65, revenue of $0.3M [8/13/2024 5:36 PM]
15-05-2024	AH		CDTX	Cidara Therapeutics	58.00	-2.28	-1.50	0.00	Cidara Therapeutics GAAP EPS of -$2.28 beats by $0.11, revenue of $8.46M misses by $0.57M [5/15/2024 5:08 PM]	12.01	-0.70 (-5.51%)	12.07	-0.64 (-5.04%)	10.00 - 29.60	44,762	40,000	3,479
Cidara Therapeutics GAAP EPS of -$2.28 beats by $0.11, revenue of $8.46M misses by $0.57M [5/15/2024 5:08 PM]
22-04-2024	AH		CDTX	Cidara Therapeutics	65.00	-0.04	-0.08	0.00	Cidara Therapeutics GAAP EPS of -$0.04 beats by $0.06, revenue of $17.6M beats by $6.06M [4/22/2024 5:19 PM]	0.5151	0.0 (0.23%)	0.55	0.03 (6.60%)	0.50 - 1.48	1,742,379	1,020,000	60,792
Cidara Therapeutics GAAP EPS of -$0.04 beats by $0.06, revenue of $17.6M beats by $6.06M [4/22/2024 5:19 PM] Cidara Therapeutics announces receipt of Nasdaq delinquency notice [4/22/2024 5:11 PM] Cidara Therapeutics to implement a reverse stock split [4/22/2024 9:39 AM]
03-08-2023	AH		CDTX	Cidara Therapeutics	94.00	-0.14	-0.08	0.00	Cidara Therapeutics GAAP EPS of -$0.14 misses by $0.01, revenue of $7.61M misses by $3.94M [8/3/2023 5:37 PM]	0.9620	-0.06 (-5.69%)	1.00	-0.02 (-1.96%)	0.46 - 2.10	499,700	750,000	2,868
Cidara Therapeutics GAAP EPS of -$0.14 misses by $0.01, revenue of $7.61M misses by $3.94M [8/3/2023 5:37 PM]
23-03-2023	PM		CDTX	Cidara Therapeutics	142.00	-0.19	-0.01	0.00	Cidara Therapeutics GAAP EPS of -$0.19 misses by $0.04, revenue of $10.22M misses by $0.35M [3/23/2023 7:53 AM]	1.44	-0.46 (-24.47%)	1.69	-0.21 (-11.05%)	0.40 - 2.10	11,465,800	5,400,000	1,212,380
Cidara Therapeutics GAAP EPS of -$0.19 misses by $0.04, revenue of $10.22M misses by $0.35M [3/23/2023 7:53 AM] Cidara stock dips amid FDA approval of antifungal drug Rezzayo [3/23/2023 4:49 AM] Deadly fungal infection sweeps across U.S. [3/22/2023 12:23 PM] Cidara extends gains ahead of FDA decision on antifungal therapy [3/22/2023 8:17 AM] Cidara off 27% despite FDA nod amid selloff in antifungal space [3/23/2023 3:43 PM]
03-11-2022	AH		CDTX	Cidara Therapeutics	41.00	0.17	0.30	0.00	Cidara Therapeutics GAAP EPS of $0.17 beats by $0.10, revenue of $40.74M beats by $18.06M [11/3/2022 5:51 PM]	0.5620	-0.01 (-1.92%)	0.58	0.01 (1.22%)	0.40 - 1.76	195,098	220,000	7,276
Cidara Therapeutics GAAP EPS of $0.17 beats by $0.10, revenue of $40.74M beats by $18.06M [11/3/2022 5:51 PM] Cidara Therapeutics (CDTX) Q3 Earnings Miss Estimates [Nov-03-22 07:05PM] Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results [Nov-03-22 05:47PM]
09-08-2022	AH		CDTX	Cidara Therapeutics	48.00	-0.19	-0.28	0.00	Cidara Therapeutics GAAP EPS of -$0.19 beats by $0.09, revenue of $6.22M beats by $0.01M [8/9/2022 5:25 PM]	0.6525	0.03 (4.38%)	0.65	0.02 (3.95%)	0.40 - 2.39	439,944	1,490,000	2,143
Cidara Therapeutics GAAP EPS of -$0.19 beats by $0.09, revenue of $6.22M beats by $0.01M [8/9/2022 5:25 PM] Cidara Therapeutics (CDTX) Reports Q2 Loss, Lags Revenue Estimates [Aug-09-22 07:25PM] Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results [Aug-09-22 05:16PM]
11-05-2022	AH	5:40 PM ET (May 11)	CDTX	Cidara Therapeutics	50.00	-0.27	-0.26	0.00	Cidara Therapeutics GAAP EPS of -$0.27 beats by $0.01, revenue of $7.11M beats by $2.4M [5/11/2022 4:56 PM]	0.4601	-0.13 (-22.65%)	0.55	-0.04 (-7.43%)	0.41 - 2.39	1,135,300	190,000	5,036
Cidara Therapeutics GAAP EPS of -$0.27 beats by $0.01, revenue of $7.11M beats by $2.4M [5/11/2022 4:56 PM] H.C. Wainwright analyst lowers price target on Cidara Therapeutics [5/12/2022 11:56 AM] Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results [May-11-22 04:13PM] Halozyme Therapeutics (HALO) Q1 Earnings and Revenues Miss Estimates [May-10-22 05:25PM] Cidara Therapeutics (CDTX) Reports Q1 Loss, Lags Revenue Estimates [May-11-22 05:35PM]
07-03-2022	AH		CDTX	Cidara Therapeutics	47.00	-0.26	-0.33	0.00	Cidara Therapeutics GAAP EPS of -$0.26, revenue of $7.2M [3/7/2022 6:07 PM]	0.7140	0.05 (7.00%)	0.0	0.0 (0.00%)	0.63 - 3.08	225,799	200,000	0
Cidara Therapeutics GAAP EPS of -$0.26, revenue of $7.2M [3/7/2022 6:07 PM] Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-07-22 05:41PM] Cidara Therapeutics (CDTX) Reports Q4 Loss, Tops Revenue Estimates [Mar-07-22 06:55PM]
10-11-2021	AH		CDTX	Cidara Therapeutics	78.00	-0.37	-0.37	0.00	Cidara Therapeutics EPS misses by $0.02, beats on revenue [11/10/2021 4:42 PM]	1.52	-0.01 (-0.65%)	1.55	0.02 (1.31%)	1.46 - 3.15	415,161	470,000	1,130
Cidara Therapeutics EPS misses by $0.02, beats on revenue [11/10/2021 4:42 PM] Cidara Provides Corporate Update and Reports Third Quarter 2021 Financial Results [Nov-10-21 04:05PM] Cidara Therapeutics (CDTX) Reports Q3 Loss, Tops Revenue Estimates [Nov-10-21 07:15PM]
13-05-2021	AH	4:45 PM ET (May 13)	CDTX	Cidara Therapeutics, Inc.	97.06	-0.39	-0.17	-0.46	Cidara Therapeutics EPS misses by $0.05, misses on revenue [5/13/2021 5:17 PM]	2.00	-0.02 (-0.99%)	2.01	-0.01 (-0.50%)	1.76 - 4.45	266,999	480,000	9,286
Cidara Therapeutics EPS misses by $0.05, misses on revenue [5/13/2021 5:17 PM] Cidara Provides Corporate Update and Reports First Quarter 2021 Financial Results [May-13-21 04:29PM] Cidara Therapeutics (CDTX) Reports Q1 Loss, Lags Revenue Estimates [May-13-21 07:35PM]
05-11-2020	AH	4:50 PM ET (Nov 5)	CDTX	Cidara Therapeutics, Inc.	104.82	-0.41	-0.48	0.08	Cidara Therapeutics EPS misses by $0.01, misses on revenue [11/5/2020 5:35 PM]	2.34	-0.20 (-7.87%)	2.50	0.02 (0.81%)	1.30 - 4.45	287,372	212,399	230

13-08-2020	AH		CDTX	Cidara Therapeutics, Inc.	165.70	-0.45	-0.23	-0.49	Cidara Therapeutics EPS misses by $0.14, misses on revenue [8/13/2020 4:59 PM]	3.78	0.0 (0.00%)	0.0	0.0 (0.00%)	1.22 - 4.45	104,321	203,500	0

13-05-2020	AH	After the close (May 13)	CDTX	Cidara Therapeutics, Inc.	132.39	-0.46	-0.34	-0.60	Cidara Therapeutics EPS misses by $0.12, beats on revenue [5/13/2020 4:58 PM]	2.99	0.07 (2.40%)	2.95	0.03 (1.03%)	1.22 - 4.44	146,384	293,949	320